What is the appropriate outpatient treatment plan for a 73-year-old woman with hypertension and dyspnea on exertion who has an echocardiogram showing normal ejection fraction and grade 1 diastolic dysfunction, and is currently taking hydrochlorothiazide 25 mg and olmesartan 20 mg daily?

Outpatient Treatment Plan

Continue current hypertension medications (olmesartan 20mg and HCTZ 25mg daily), optimize blood pressure control to target <130/80 mmHg, add a calcium channel blocker if BP remains elevated, use diuretics judiciously for symptom relief, and investigate other causes of dyspnea beyond the mild diastolic dysfunction.

Blood Pressure Management

Your patient is already on appropriate first-line therapy with an ARB (olmesartan) and thiazide diuretic (HCTZ). According to the 2020 ISH guidelines, the target BP for this 73-year-old should be <130/80 mmHg, though individualized based on frailty 1. The 2024 ESC guidelines similarly recommend BP <140/90 mmHg as a minimum target 2.

Current medication assessment:

• Olmesartan 20mg is at the standard starting dose; FDA labeling shows 40mg daily provides additional BP reduction (approximately 12/7 mmHg vs 10/6 mmHg with 20mg) 3
• HCTZ 25mg is appropriate dosing
• If BP is not at target, the next step per ISH guidelines is to add a dihydropyridine calcium channel blocker (amlodipine or similar) to create a three-drug combination 1

Medication titration algorithm:

1. First: Verify current BP control with home BP monitoring (target <135/85 mmHg at home) 1
2. If BP elevated: Increase olmesartan to 40mg daily 3
3. If still not controlled: Add amlodipine 5-10mg daily (preferred three-drug combination: ARB + CCB + thiazide diuretic) 1, 2
4. Consider single-pill combinations to improve adherence 2, 4

Diastolic Dysfunction Management

Grade 1 diastolic dysfunction with normal EF represents early/mild diastolic impairment and is common in elderly hypertensive patients. The 1995 ACC/AHA guidelines specifically address this 5:

Key management principles:

• Diuretics: Use cautiously for symptom control; small doses initially as these patients are prone to hypotension due to dependence on elevated filling pressures 5
• Avoid volume depletion: The patient needs adequate preload; aggressive diuresis can reduce cardiac output 5
• Beta-blockers: May improve diastolic filling by reducing heart rate, though not first-line for grade 1 dysfunction 5
• ACE inhibitors/ARBs: Already on olmesartan, which is appropriate; continue current therapy 5
• Avoid: Positive inotropes (not needed with normal systolic function) 5

Addressing Dyspnea on Exertion

Critical caveat: Grade 1 diastolic dysfunction with normal EF typically does NOT cause significant dyspnea on exertion 6, 7. You must evaluate other causes:

Workup needed:

• Assess volume status clinically (JVP, peripheral edema, lung exam)
• Check BNP/NT-proBNP levels (should be low-normal with grade 1 dysfunction)
• Rule out: anemia, thyroid disease, pulmonary disease (COPD, ILD), deconditioning, obesity 5, 8
• Consider cardiopulmonary exercise testing if diagnosis unclear
• Evaluate for coronary ischemia if risk factors present 8

Specific Treatment Recommendations

Medications to continue:

• Olmesartan 20mg daily (consider increasing to 40mg if BP not at target)
• HCTZ 25mg daily

Medications to consider adding:

• Amlodipine 5-10mg daily if BP >130/80 mmHg after olmesartan uptitration 1, 2
• Low-dose loop or thiazide diuretic ONLY if volume overload symptoms present (use cautiously) 5

Medications to AVOID:

• Non-dihydropyridine CCBs (diltiazem, verapamil) - negative inotropic effects 9
• Alpha-blockers as primary therapy 9
• Aggressive diuresis without clear volume overload 5

Monitoring Plan

Within 2-4 weeks:

• Home BP monitoring (target <135/85 mmHg)
• Assess symptom response
• Check basic metabolic panel (potassium, creatinine)

Within 3 months:

• Achieve BP target <130/80 mmHg 1, 2
• Re-evaluate dyspnea; if persistent despite BP control, pursue alternative diagnoses
• Consider repeat echo only if clinical status changes significantly

Lifestyle interventions (essential concurrent therapy):

• Sodium restriction (<2g/day)
• Weight management if overweight
• Regular moderate exercise (walking, cycling) - avoid isometric exercise 5
• Avoid NSAIDs 8

Important pitfall: Do not attribute all dyspnea to mild diastolic dysfunction. Grade 1 dysfunction is often an incidental finding in elderly hypertensive patients and may not be the primary cause of symptoms 6, 7. The normal EF and only mild diastolic abnormality suggest another etiology for her dyspnea should be actively sought.